Signal active
Organization
Contact Information
Overview
MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
About
Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma
2015
1-10
Headquarters locations
La Jolla, California, United States, North America
Social
Profile Resume
MatriSys Bioscience headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $360.0M in funding across 80 round(s). With a team of 1-10 employees, MatriSys Bioscience is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - MatriSys Bioscience, raised $1.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
1
0
$4.5M
Details
1
MatriSys Bioscience has raised a total of $4.5M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed |
Investors
MatriSys Bioscience is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
MatriSys Bioscience | - | FUNDING ROUND - MatriSys Bioscience | 3.0M |
Primer Capital | - | FUNDING ROUND - Primer Capital | 3.0M |
MatriSys Bioscience | - | FUNDING ROUND - MatriSys Bioscience | 1.5M |
Tech Coast Angels | - | FUNDING ROUND - Tech Coast Angels | 1.5M |
Recent Activity
Funding Round
Mar 11, 2021
MatriSys Bioscience raised $3000000 on 2021-03-11 in Convertible Note
Funding Round
Oct 01, 2019
MatriSys Bioscience raised an undisclosed amount on 2019-10-01 in Venture Round
Funding Round
Oct 08, 2018
MatriSys Bioscience raised an undisclosed amount on 2018-10-08 in Seed Round
Funding Round
Jan 05, 2017
MatriSys Bioscience raised $1500000 on 2017-01-05 in Convertible Note